Yes, it has been a cockup but what's the point of dwelling on...

Yes, it has been a cockup but what's the point of dwelling on that when in my view the bottom line remains the fact that TIS hold the exclusive world-wide rights to the product which is a not only a highly cost-effective and significant breakthrough in the treatment of ulcers but has other potential applications too.

The product is exceptional and will fly through any US or other trials!

Sooner or later it will be on the market - through TIS or another company. One concern I do have relates the the longevity of the stockpile of the product currently held in wharehouses.

Anyway, I'm looking to buy some more around 15c which by chance is the price I first bought in what seems like years ago. I view it as a good long-term buy.